NAMS Stock: Price, Earnings History and SEC Filings
NewAmsterdam Pharma Company N.V. (NAMS) last traded at $20.06, down 3.37% on the latest session and down 17.5% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.52 against an analyst estimate of $-0.48, a miss of 8.3%.
$20.06 -3.37%
1 month-17.52%
52-week high$42.21
52-week low$19.13
Volume1.14M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NAMS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $-0.52 | $-0.48 | -8.33% |
| Mar 2026 | May 7, 2026 | $-0.40 | $-0.46 | +13.04% |
| Dec 2025 | Feb 18, 2026 | $-0.63 | $-0.40 | -57.50% |
| Sep 2025 | Nov 5, 2025 | $-0.41 | $-0.38 | -7.89% |
NAMS beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for NAMS
SEC filing data is not available right now. You can search for NAMS on SEC EDGAR.
NAMS news
No recent headlines found. The live terminal has the full news feed.
About NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Company N.V. (NAMS) is a US-listed public company on Nasdaq.